Additionally, these IDO1-overexpression ovarian cancer cell-derived EVs were also found to enhance endothelial IDO1expression, in contrast to EVs from IDO1-knockdown or -control ovarian cancer cells (Fig. 8e). This evidence concerns the gene IDO1 and ovarian cancer.